UCB to focus on core business in India
1 April 2015 | By Victoria White
UCB has announced it has entered an agreement with Dr. Reddy’s to sell its established brands in India, allowing it to focus on its neurology portfolio...
List view / Grid view
News
Unified Chromatography: The Swiss Knife of analytics
31 March 2015 | By Shimadzu
Shimadzu, one of the world leaders in analytical instrumentation, has released the new Nexera UC SFE/SFC/MS platform combining quick and easy on-line sample extraction with state-of-the-art chromatographic separation and high sensitivity detection...
Quotient Clinical announces ADME success in oncology
31 March 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced contract wins for three further OncoADME programs to support clinical mass balance/ADME investigations in cancer patients...
Syndax and Merck to collaborate on immuno-oncology study evaluating entinostat in combination with Keytruda in lung cancer and melanoma
31 March 2015 | By Victoria White
Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat with Keytruda (pembrolizumab)...
Boost for children’s understanding of healthcare rights and the NHS Constitution
31 March 2015 | By Victoria White
National Children's Bureau and Council for Disabled Children have published information to improve children's understanding of the NHS Constitution...
New post-hoc analyses extend understanding of the efficacy and safety of lurasidone in the treatment of schizophrenia
31 March 2015 | By Victoria White
Takeda and Sunovion today announced the results from 3 post-hoc analyses evaluating the efficacy and safety of lurasidone in patients with schizophrenia...
FDA approves Jadenu to simplify treatment administration for patients with chronic iron overload
31 March 2015 | By Victoria White
Novartis has announced that the FDA has approved Jadenu tablets, a new oral formulation of Exjade® tablets, for the treatment of chronic iron overload...
EMA validates Marketing Authorisation Application for Zinbryta for treatment of MS
31 March 2015 | By Victoria White
Biogen and AbbVie have announced that the EMA has validated the companies’ MAA for Zinbryta for the treatment of relapsing forms of MS in the EU...
FDA grants Amgen priority review for Kyprolis for the treatment of relapsed multiple myeloma
31 March 2015 | By Victoria White
Amgen has announced that the FDA has accepted the sNDA of Kyprolis for the treatment of patients with relapsed multiple myeloma...
Biodelivery Sciences announces primary endpoint in Phase 3 study of Clonidine Topical Gel for painful diabetic neuropathy not met
30 March 2015 | By Victoria White
BioDelivery Sciences announced that Clonidine Topical Gel did not meet statistical significance compared to placebo in the Phase 3 clinical study...
New advanced validation system from Kaye
30 March 2015 | By Amphenol
Amphenol Advanced Sensors’ Kaye products is pleased to launch the new advanced validation System Kaye Validator AVS at Interphex Show, 21-23 April, New York...
New research reveals significant burden for patients being treated for sight threatening retinal disease
30 March 2015 | By Victoria White
New data show that the intravitreal injection regimens associated with treating retinal disease can have a detrimental effect on patient quality of life....
See the light with Tecan’s Infinite® M200 PRO
30 March 2015 | By kdm communications
Tecan’s Infinite® M200 PRO reader has helped Californian company Sevident to establish rapid, sensitive immunofluorescence and colorimetric assays based on its proprietary NETs technology...
UCB secures multi-million pound funding boost from UK Government
UCB has announced that its joint bid with five other UK-based organisations has been selected as a recipient of the Government’s 2014 Advanced Manufacturing Supply Chain Initiative (AMSCI), which will result in a £6.2 million grant to support the development of novel biologic treatments.
Stallergenes announces the approval in Japan of STG320, the first sublingual immunotherapy tablet for the treatment of house dust mite allergy
30 March 2015 | By Victoria White
Stallergenes has announced that its partner, Shionogi & Co., Ltd has received the approval of STG320 from the Japanese health authorities...
